Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies.

MLA

Henry, D. H., and R. I. Abels. “Recombinant Human Erythropoietin in the Treatment of Cancer and Chemotherapy-Induced Anemia: Results of Double-Blind and Open-Label Follow-up Studies.” Seminars in Oncology, vol. 21, no. 2 Suppl 3, Apr. 1994, pp. 21–28. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=8202722&authtype=sso&custid=ns315887.

APA

Henry, D. H., & Abels, R. I. (1994). Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies. Seminars in Oncology, 21(2 Suppl 3), 21–28.

Chicago

Henry, D H, and R I Abels. 1994. “Recombinant Human Erythropoietin in the Treatment of Cancer and Chemotherapy-Induced Anemia: Results of Double-Blind and Open-Label Follow-up Studies.” Seminars in Oncology 21 (2 Suppl 3): 21–28. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=8202722&authtype=sso&custid=ns315887.